Skip to content

Clinical trials

Phase 1 Alzheimer Disease trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 1 Country / region: Sweden Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20077
20082
20091
20103
20111
20123
20131
20141
20151
20183
20201
20212
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
AlzeCure Pharma3
H. Lundbeck A/S3
Hoffmann-La Roche3
GlaxoSmithKline2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
Pfizer2
Bayer1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease30
Cognition Disorders3
Brain Diseases1
Central Nervous System Diseases1
Cognitive Dysfunction1
Dementia1
Lymphoma, Follicular1
Memory Disorders1
Nervous System Diseases1
Neurocognitive Disorders1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.